PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Every official PROVECTUS BIOPHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

PROVECTUS BIOPHARMACEUTICALS, INC. documents

• PROVECTUS BIOPHARMACEUTICALS, INC. 10-K 2026PVCT 10-K 2026: annual report for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-K 2025PVCT 10-K 2025: annual report for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-K 2024PVCT 10-K 2024: annual report for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-K 2023PVCT 10-K 2023: annual report for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-K 2022PVCT 10-K 2022: annual report for fiscal 2022
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-Q 2026PVCT 10-Q 2026: quarterly report for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-Q 2025PVCT 10-Q 2025: quarterly report for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-Q 2024PVCT 10-Q 2024: quarterly report for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-Q 2023PVCT 10-Q 2023: quarterly report for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. 10-Q 2022PVCT 10-Q 2022: quarterly report for fiscal 2022
• PROVECTUS BIOPHARMACEUTICALS, INC. 8-K 2026PVCT 8-K 2026: current report for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. 8-K 2025PVCT 8-K 2025: current report for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. 8-K 2024PVCT 8-K 2024: current report for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. 8-K 2023PVCT 8-K 2023: current report for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. 8-K 2022PVCT 8-K 2022: current report for fiscal 2022
• PROVECTUS BIOPHARMACEUTICALS, INC. DEF 14A 2026PVCT DEF 14A 2026: proxy statement for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. DEF 14A 2025PVCT DEF 14A 2025: proxy statement for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. DEF 14A 2024PVCT DEF 14A 2024: proxy statement for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. DEF 14A 2023PVCT DEF 14A 2023: proxy statement for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. DEF 14A 2022PVCT DEF 14A 2022: proxy statement for fiscal 2022
• PROVECTUS BIOPHARMACEUTICALS, INC. Form 4 2026PVCT Form 4 2026: insider trading filing for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. Form 4 2025PVCT Form 4 2025: insider trading filing for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. Form 4 2024PVCT Form 4 2024: insider trading filing for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. Form 4 2023PVCT Form 4 2023: insider trading filing for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. Form 4 2022PVCT Form 4 2022: insider trading filing for fiscal 2022
• PROVECTUS BIOPHARMACEUTICALS, INC. S-1 2026PVCT S-1 2026: registration statement for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. S-1 2025PVCT S-1 2025: registration statement for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. S-1 2024PVCT S-1 2024: registration statement for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. S-1 2023PVCT S-1 2023: registration statement for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. S-1 2022PVCT S-1 2022: registration statement for fiscal 2022
• PROVECTUS BIOPHARMACEUTICALS, INC. 13F 2026PVCT 13F 2026: institutional holdings for fiscal 2026
• PROVECTUS BIOPHARMACEUTICALS, INC. 13F 2025PVCT 13F 2025: institutional holdings for fiscal 2025
• PROVECTUS BIOPHARMACEUTICALS, INC. 13F 2024PVCT 13F 2024: institutional holdings for fiscal 2024
• PROVECTUS BIOPHARMACEUTICALS, INC. 13F 2023PVCT 13F 2023: institutional holdings for fiscal 2023
• PROVECTUS BIOPHARMACEUTICALS, INC. 13F 2022PVCT 13F 2022: institutional holdings for fiscal 2022

More companies